Authors : Özgür Yurttaş N; Division of Hematology, Department of Internal Medicine, Cerrahpasa Faculty of Medicine, Istanbul University, Istanbul, Turkey.; Eşkazan AE

Subjects: Dasatinib/Dasatinib/Dasatinib/*adverse effects ; Hypertension, Pulmonary/Hypertension, Pulmonary/Hypertension, Pulmonary/*chemically induced; Echocardiography

Source: British journal of clinical pharmacology [Br J Clin Pharmacol] 2018 May; Vol. 84 (5), pp. 835-845. Date of Electronic Publication: 2018 Mar 06.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 7503323 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list

Academic Journal

Incidence of heart failure following exposure to a protein kinase inhibitor, a French population-based study.

Authors : Zelmat, Yoann; Conte, Cécile; Noize, Pernelle

Subjects: PROTEIN kinase inhibitors; HEART failure; DRUG side effects

Source: British Journal of Clinical Pharmacology; Apr2023, Vol. 89 Issue 4, p1338-1348, 11p

Record details

Read More Add to Saved list

Academic Journal

Pleural adverse drugs reactions and protein kinase inhibitors: Identification of suspicious targets by disproportionality analysis from VigiBase.

Authors : Mahé, Julien; de Campaigno, Emilie Patras; Chené, Anne‐Laure

Subjects: DASATINIB; DRUG side effects; PROTEIN kinase inhibitorsWORLD Health Organization

Source: British Journal of Clinical Pharmacology; Oct2018, Vol. 84 Issue 10, p2373-2383, 11p, 5 Charts, 1 Graph

Record details

Read More Add to Saved list

Academic Journal

Effect of esomeprazole on the oral absorption of dasatinib in a patient with Philadelphia-positive acute lymphoblastic leukemia.

Authors : Pape, Elise; Michel, Delphine; Scala‐Bertola, Julien

Subjects: CHRONIC myeloid leukemia; B cells; FATE mapping (Genetics)

Source: British Journal of Clinical Pharmacology; Jun2016, Vol. 81 Issue 6, p1195-1196, 2p

Record details

Read More Add to Saved list

Academic Journal

Haematological adverse events associated with tyrosine kinase inhibitors in chronic myeloid leukaemia: A network meta‐analysis.

Authors : Fachi, Mariana M.; Tonin, Fernanda S.; Leonart, Leticia P.

Subjects: CHRONIC myeloid leukemia; PROTEIN-tyrosine kinases; KINASE inhibitors

Source: British Journal of Clinical Pharmacology; Oct2019, Vol. 85 Issue 10, p2280-2291, 12p, 2 Diagrams, 4 Charts

Record details

Read More Add to Saved list

Academic Journal

Tyrosine kinase inhibitors (TKIs) used in the management of chronic myeloid leukaemia are associated with haematologic toxicities—Which TKI is the safest?

Authors : Eşkazan, Ahmet Emre

Subjects: CHRONIC myeloid leukemia; NILOTINIB; PROTEIN-tyrosine kinases

Source: British Journal of Clinical Pharmacology; Oct2019, Vol. 85 Issue 10, p2241-2243, 3p

Record details

Read More Add to Saved list

Academic Journal

Identifying new drugs associated with pulmonary arterial hypertension: A WHO pharmacovigilance database disproportionality analysis.

Authors : Hlavaty, Alex; Roustit, Matthieu; Montani, David

Subjects: PULMONARY arterial hypertension; DRUG side effects; DRUGS of abuseWORLD Health Organization

Source: British Journal of Clinical Pharmacology; Dec2022, Vol. 88 Issue 12, p5227-5237, 11p

Record details

Read More Add to Saved list

Academic Journal

Identification of cellular targets involved in cardiac failure caused by PKI in oncology: an approach combining pharmacovigilance and pharmacodynamics.

Authors : Patras de Campaigno, Emilie; Bondon ‐ Guitton, Emmanuelle; Laurent, Guy

Subjects: HEART failure; ONCOLOGY; PROTEIN kinase inhibitors

Source: British Journal of Clinical Pharmacology; Jul2017, Vol. 83 Issue 7, p1544-1555, 12p

Record details

Read More Add to Saved list

Academic Journal

Inhibition of paracetamol glucuronidation by tyrosine kinase inhibitors.

Authors : Liu, Yong; Ramírez, Jacqueline; Ratain, Mark J.

Subjects: ACETAMINOPHEN; PROTEIN-tyrosine kinases; HEPATOTOXICOLOGY

Source: British Journal of Clinical Pharmacology; Jun2011, Vol. 71 Issue 6, p917-920, 4p, 1 Chart, 1 Graph

Record details

Read More Add to Saved list

Academic Journal

Effect of a proton pump inhibitor on the pharmacokinetics of imatinib.

Authors : Egorin, Merrill J.; Shah, Dhvani D.; Christner, Susan M.

Subjects: IMATINIB; PROTON pump inhibitors; ENZYME inhibitors

Source: British Journal of Clinical Pharmacology; Sep2009, Vol. 68 Issue 3, p370-374, 5p, 1 Diagram, 1 Chart, 2 Graphs

Record details

Read More Add to Saved list

menu

Search Results

Your Filters

Dasatinib-induced pulmonary arterial hypertension.

Incidence of heart failure following exposure to a protein kinase inhibitor, a French population-based study.

Pleural adverse drugs reactions and protein kinase inhibitors: Identification of suspicious targets by disproportionality analysis from VigiBase.

Effect of esomeprazole on the oral absorption of dasatinib in a patient with Philadelphia-positive acute lymphoblastic leukemia.

Haematological adverse events associated with tyrosine kinase inhibitors in chronic myeloid leukaemia: A network meta‐analysis.

Tyrosine kinase inhibitors (TKIs) used in the management of chronic myeloid leukaemia are associated with haematologic toxicities—Which TKI is the safest?

Identifying new drugs associated with pulmonary arterial hypertension: A WHO pharmacovigilance database disproportionality analysis.

Identification of cellular targets involved in cardiac failure caused by PKI in oncology: an approach combining pharmacovigilance and pharmacodynamics.

Inhibition of paracetamol glucuronidation by tyrosine kinase inhibitors.

Effect of a proton pump inhibitor on the pharmacokinetics of imatinib.

Contact CCPL

Patron Login

menu

Search Results

Your Filters

Engage with CCPL

Contact CCPL